Search research articles
Contact Us
Filters
Showing results (271-280 of 401) with videos related to
Page
of 41
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
Gary A Ulaner, Cristina Saura, Sarina A Piha-Paul, et al.
The Journal of Molecular Diagnostics : JMD
|
December 29, 2016
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay
Dara S Ross, Ahmet Zehir, Donavan T Cheng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2019
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
R Condorelli, F Mosele, B Verret, et al.
Neuro-Oncology
|
January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series
Ankush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
European Biophysics Journal : EBJ
|
February 17, 2025
A paradigm shift: analytical ultracentrifugation as a multi-attribute platform method in targeted protein degradation
Alexander E Yarawsky, Judith A Ronau, Tiffany A Thibaudeau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2020
Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients
D S Ross, B Liu, A M Schram, et al.
JAMA Oncology
|
June 7, 2018
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan N Ptashkin, Diana L Mandelker, Catherine C Coombs, et al.
Nature Medicine
|
May 12, 2026
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial
Louis J Aronne, Deborah B Horn, Carel W le Roux, et al.
Blood Advances
|
March 29, 2019
A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease
Eli L Diamond, Anne S Reiner, Justin J Buthorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing
Martee L Hensley, Shweta S Chavan, David B Solit, et al.
Page
of 41
Search research articles
Search
Showing results (271-280 of 401) with videos related to
Sort By:
Page
of 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
Gary A Ulaner, Cristina Saura, Sarina A Piha-Paul, et al.
The Journal of Molecular Diagnostics : JMD
|
December 29, 2016
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay
Dara S Ross, Ahmet Zehir, Donavan T Cheng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2019
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
R Condorelli, F Mosele, B Verret, et al.
Neuro-Oncology
|
January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series
Ankush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
European Biophysics Journal : EBJ
|
February 17, 2025
A paradigm shift: analytical ultracentrifugation as a multi-attribute platform method in targeted protein degradation
Alexander E Yarawsky, Judith A Ronau, Tiffany A Thibaudeau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2020
Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients
D S Ross, B Liu, A M Schram, et al.
JAMA Oncology
|
June 7, 2018
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan N Ptashkin, Diana L Mandelker, Catherine C Coombs, et al.
Nature Medicine
|
May 12, 2026
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial
Louis J Aronne, Deborah B Horn, Carel W le Roux, et al.
Blood Advances
|
March 29, 2019
A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease
Eli L Diamond, Anne S Reiner, Justin J Buthorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing
Martee L Hensley, Shweta S Chavan, David B Solit, et al.
Page
of 41